Long intergenic non-protein coding RNA 1273 confers sorafenib resistance in hepatocellular carcinoma via regulation of methyltransferase 3

Hepatocellular carcinoma (HCC) is often diagnosed in patients with advanced disease who are ineligible for curative surgical therapies. Sorafenib is a first-line agent approved for the treatment of advanced HCC. However, the frequent resistance of HCC cells to sorafenib greatly reduces its efficacy....

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Huifang, Sun, Jie, Zhang, Wei, Zhang, Huixin, Li, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973700/
https://www.ncbi.nlm.nih.gov/pubmed/35037556
http://dx.doi.org/10.1080/21655979.2022.2025701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973700/
https://www.ncbi.nlm.nih.gov/pubmed/35037556
http://dx.doi.org/10.1080/21655979.2022.2025701

Ejemplares similares